Fundraising FoxADmit Therapeutics
Barcelona, ES · 4 known investors
Find your way into ADmit Therapeutics
Sign up to see every warm intro you have to ADmit Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ADmit Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Admit Therapeutics is a diagnostics and pharmaceutical company focused on neurological diseases, particularly Alzheimer's and dementia, leveraging AI/ML for biomarker analysis and clinical laboratory services. The company serves medical institutions and healthcare providers developing and deploying advanced diagnostic solutions.
Founders & leadership
MB
Marta BarrachinaCEO, Co-Founder
RR
Ramón ReñéCo-Founder
JG
Jordi GascónCo-Founder
Investors · 4
Frequently asked questions
- What does ADmit Therapeutics do?
- Admit Therapeutics is a diagnostics and pharmaceutical company focused on neurological diseases, particularly Alzheimer's and dementia, leveraging AI/ML for biomarker analysis and clinical laboratory services. The company serves medical institutions and healthcare providers developing and deploying advanced diagnostic solutions.
- Who founded ADmit Therapeutics?
- ADmit Therapeutics was founded by Marta Barrachina, Ramón Reñé, Jordi Gascón.
- Who are ADmit Therapeutics's investors?
- ADmit Therapeutics's investors include BStartup, Ship2B, WA4STEAM, Clave Capital.
- Where is ADmit Therapeutics headquartered?
- ADmit Therapeutics is headquartered in Barcelona, ES.